阿昔洛韦钠,CAS 登记号 69657-51-8,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 阿昔洛韦钠 的 CAS 号:69657-51-8,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Acyclovir sodium · CAS 69657-51-8 · C8H10N5NaO3. UNII 927L42J563.
| CAS Registry Number | 69657-51-8 |
|---|---|
| PubChem CID | 23665721 |
| Molecular formula | C8H10N5NaO3 |
| IUPAC name | sodium 2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate |
| UNII (FDA) | 927L42J563 |
| Molecular Weight | 247.19 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 247.06813348 |
| Monoisotopic Mass | 247.06813348 |
| Topological Polar Surface Area | 122 |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 237 |
| Reported hazard statements | H315 (50%), H317 (50%), H319 (50%), H335 (50%), H412 (50%) |
|---|
H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]
H317 (50%): May cause an allergic skin reaction [Warning Sensitization, Skin]
ACYCLOVIR SODIUM; Aciclovir sodium; 69657-51-8; Acyclovir sodium salt; Sodium acyclovir; BW-248U Sodium; BW248U SODIUM; BW-248U-SODIUM; 9-((2-Hydroxyethoxy)methyl)guanine monosodium salt; ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE; 927L42J563; DTXSID90989774; Zovirax for Injection; RefChem:57187; DTXCID201510797; 2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one Momsodium Salt
CAS 69657-51-8; molecular formula C8H10N5NaO3; molecular weight — g/mol.
ACYCLOVIR SODIUM, Aciclovir sodium, 69657-51-8, Acyclovir sodium salt, Sodium acyclovir, BW-248U Sodium.
Hazard statements reported: H315, H317, H319, H335, H412.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.